ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · IEX Real-Time Price · USD
0.835
-0.009 (-1.10%)
At close: Jul 19, 2024, 4:00 PM
0.820
-0.015 (-1.80%)
Pre-market: Jul 22, 2024, 7:20 AM EDT
ImmunoPrecise Antibodies Market Cap
ImmunoPrecise Antibodies has a market cap or net worth of $21.97 million as of July 22, 2024. Its market cap has decreased by -70.93% in one year.
Market Cap
21.97M
Enterprise Value
27.87M
1-Year Change
-70.93%
Ranking
Category
Stock Price
$0.84
Market Cap Chart
Since December 31, 2020, ImmunoPrecise Antibodies's market cap has decreased from $250.60M to $21.97M, a decrease of -91.23%. That is a compound annual growth rate of -49.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 22.00M | -48.60% |
| Dec 29, 2023 | 42.80M | -67.05% |
| Dec 30, 2022 | 129.90M | 25.14% |
| Dec 31, 2021 | 103.80M | -58.58% |
| Dec 31, 2020 | 250.60M | - |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sol-Gel Technologies | 22.87M |
| Anew Medical | 22.39M |
| Nephros | 22.25M |
| Inspira Technologies Oxy B.H.N. | 22.21M |
| Ekso Bionics Holdings | 22.08M |
| Minerva Neurosciences | 21.96M |
| Gain Therapeutics | 21.84M |
| Aprea Therapeutics | 21.72M |